Literature DB >> 9573382

Suppression by topiramate of epileptiform burst discharges in hippocampal CA3 neurons of spontaneously epileptic rat in vitro.

R Hanaya1, M Sasa, H Ujihara, K Ishihara, T Serikawa, K Iida, T Akimitsu, K Arita, K Kurisu.   

Abstract

Topiramate, a novel antiepileptic drug, inhibits the seizures of spontaneously epileptic rat (SER), a double mutant (zi/zi, tm/tm) which exhibits both tonic convulsion and absence-like seizures from the age of 8-weeks. Hippocampal CA3 pyramidal neurons in SER show a long-lasting depolarization shift with accompanying repetitive firing when a single electrostimulation is delivered to the mossy fibers in vitro. The effects of topiramate on the excitability of CA3 pyramidal neurons in SER were examined to elucidate the mechanism underlying the antiepileptic action. Intracellular recordings were performed in 23 hippocampal slice preparations of 16 SER aged 8-17 weeks. Topiramate (10-100 microM) dose-dependently inhibited the depolarizing shifts with repetitive firing induced by mossy fiber stimulation without affecting the first spike and resting membrane potentials in hippocampal CA3 neurons of SER. Higher dose of topiramate (100 microM) sometimes inhibited the first spike, and decreased excitatory postsynaptic potentials in the SER CA3 neurons. However, topiramate up to 100 microM did not affect the single action potential elicited by the stimulation in the hippocampal CA3 neurons of age-matched Wistar rat devoid of the seizure. Application of topiramate (100 microM) did not significantly affect the firing induced by depolarizing pulse applied in the CA3 neurons of the SER. In addition, topiramate (100 microM) had no effects on the Ca2+ spike induced by intracellularly applied depolarizing pulse in the presence of tetrodotoxin and tetraethylammonium. In contrast, a dose-dependent inhibition of depolarization and repetitive firing induced by bath application of glutamate in CA3 pyramidal neurons was obtained with topiramate (10-100 microM). Furthermore, topiramate (100 microM) decreased the number of miniature postsynaptic potential of CA3 pyramidal neurons of SER. In patch clamp whole cell recording using acutely dissociated hippocampal CA3 neurons from SER aged 8-weeks and age-matched normal Wistar rats, there were no remarkable effects on voltage dependent Ca2+ current with topiramate up to 300 microM in either animal; the current was completely blocked by Cd2+ at a concentration of 1 mM. These findings suggest that topiramate inhibits release of glutamate from the nerve terminals and/or abnormal firing of the CA3 pyramidal neurons of SER by mainly blocking glutamate receptors in the neurons. Copyright 1998 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9573382     DOI: 10.1016/s0006-8993(98)00116-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

Review 1.  Topiramate for juvenile myoclonic epilepsy.

Authors:  Jia Liu; Yao-Jun Tai; Lu-Ning Wang
Journal:  Cochrane Database Syst Rev       Date:  2021-11-24

Review 2.  Progress in neuroprotective strategies for preventing epilepsy.

Authors:  Munjal M Acharya; Bharathi Hattiangady; Ashok K Shetty
Journal:  Prog Neurobiol       Date:  2007-12-08       Impact factor: 11.685

3.  Topiramate modulates pH of hippocampal CA3 neurons by combined effects on carbonic anhydrase and Cl-/HCO3- exchange.

Authors:  Tobias Leniger; Jan Thöne; Martin Wiemann
Journal:  Br J Pharmacol       Date:  2004-06-14       Impact factor: 8.739

Review 4.  Molecular mechanisms of antiseizure drug activity at GABAA receptors.

Authors:  L John Greenfield
Journal:  Seizure       Date:  2013-05-14       Impact factor: 3.184

5.  Topiramate hyperpolarizes and modulates the slow poststimulus AHP of rat olfactory cortical neurones in vitro.

Authors:  Emilio Russo; Andrew Constanti
Journal:  Br J Pharmacol       Date:  2003-12-22       Impact factor: 8.739

Review 6.  Advances on genetic rat models of epilepsy.

Authors:  Tadao Serikawa; Tomoji Mashimo; Takashi Kuramoro; Birger Voigt; Yukihiro Ohno; Masashi Sasa
Journal:  Exp Anim       Date:  2014-10-14

Review 7.  Sleep Related Epilepsy and Pharmacotherapy: An Insight.

Authors:  Jaya Kumar; Amro Solaiman; Pasuk Mahakkanukrauh; Rashidi Mohamed; Srijit Das
Journal:  Front Pharmacol       Date:  2018-09-27       Impact factor: 5.810

8.  Treatment of myoclonic seizures in patients with juvenile myoclonic epilepsy.

Authors:  Stéphane Auvin
Journal:  Neuropsychiatr Dis Treat       Date:  2007-12       Impact factor: 2.570

9.  Topiramate for juvenile myoclonic epilepsy.

Authors:  Jia Liu; Lu-Ning Wang; Yu-Ping Wang
Journal:  Cochrane Database Syst Rev       Date:  2019-01-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.